Viracta Therapeutics, Inc. Quarterly Operating Lease, Right-of-Use Asset in USD from Q1 2019 to Q3 2024

Taxonomy & unit
us-gaap: USD
Description
Amount of lessee's right to use underlying asset under operating lease.
Summary
Viracta Therapeutics, Inc. quarterly Operating Lease, Right-of-Use Asset history and growth rate from Q1 2019 to Q3 2024.
  • Viracta Therapeutics, Inc. Operating Lease, Right-of-Use Asset for the quarter ending September 30, 2024 was $0.000, a 100% decline year-over-year.
Operating Lease, Right-of-Use Asset, Quarterly (USD)
Operating Lease, Right-of-Use Asset, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date Report Filed
Q3 2024 $0 -$371K -100% Sep 30, 2024 10-Q 2024-11-13
Q2 2024 $71K -$390K -84.6% Jun 30, 2024 10-Q 2024-08-14
Q1 2024 $175K -$377K -68.3% Mar 31, 2024 10-Q 2024-05-09
Q4 2023 $274K +$8K +3.01% Dec 31, 2023 10-Q 2024-11-13
Q3 2023 $371K +$9K +2.49% Sep 30, 2023 10-Q 2023-11-09
Q2 2023 $461K +$5K +1.1% Jun 30, 2023 10-Q 2023-08-14
Q1 2023 $552K +$3K +0.55% Mar 31, 2023 10-Q 2023-05-09
Q4 2022 $266K -$374K -58.4% Dec 31, 2022 10-K 2024-03-07
Q3 2022 $362K -$367K -50.3% Sep 30, 2022 10-Q 2022-11-10
Q2 2022 $456K -$360K -44.1% Jun 30, 2022 10-Q 2022-08-09
Q1 2022 $549K -$489K -47.1% Mar 31, 2022 10-Q 2022-05-10
Q4 2021 $640K -$346K -35.1% Dec 31, 2021 10-K 2023-03-14
Q3 2021 $729K +$320K +78.2% Sep 30, 2021 10-Q 2021-11-10
Q2 2021 $816K +$271K +49.7% Jun 30, 2021 10-Q 2021-08-12
Q1 2021 $1.04M +$357K +52.4% Mar 31, 2021 10-Q 2021-05-13
Q4 2020 $986K +$871K +754% Dec 31, 2020 10-K 2022-03-17
Q3 2020 $409K -$545K -57.1% Sep 30, 2020 10-Q 2020-11-16
Q2 2020 $545K -$545K -50% Jun 30, 2020 10-Q 2020-08-11
Q1 2020 $681K -$545K -44.5% Mar 31, 2020 10-Q 2020-05-07
Q4 2019 $115K Dec 31, 2019 8-K/A 2021-03-23
Q3 2019 $954K Sep 30, 2019 10-Q 2019-11-12
Q2 2019 $1.09M Jun 30, 2019 10-Q 2019-08-07
Q1 2019 $1.23M Mar 31, 2019 10-Q 2019-05-08
* An asterisk sign (*) next to the value indicates that the value is likely invalid.